Placeholder image for Sassan M. Azad, Clinical Research SOP Committee Co-Chair at N2 Canada.
Sassan M. Azad
N2 Clinical Research SOP Committee Co-Chair
Director, Medical & Scientific Affairs at A.I. Vali Inc.

Sassan Azad is a seasoned clinical research and med-tech executive with a unique dual role in both the innovation and healthcare sectors. As Director of Medical & Scientific Affairs at A.I. Vali Inc., a Toronto-based med-tech company, he leads the development and commercialization of AI-powered medical imaging platforms. Under his leadership, A.I. Vali launched AIDREA, a flagship AI-driven tool that delivers real-time analysis and instant reporting for enhanced cancer detection. The company has achieved ISO 13485 certification and support from the Vector Institute’s FastLane program.

In parallel, Sassan co-founded AzadMedica, a health research consultancy advancing clinical research and digital-health innovation in rural Ontario. He brings extensive project leadership and regulatory expertise—backed by his credentials as a certified clinical research professional (ACRP‑CP®) and Project Management Professional (PMP)—to support evidence generation, regulatory compliance, and AI integration across health ecosystems.

A strong advocate for responsible AI, Sassan frequently shares insights on integrating AI into clinical trials and patient-facing materials, including lay summaries. In 2025, he represented A.I. Vali at high-profile events such as IPON and the Medical Affairs Professional Society (MAPS) Americas Conference, serving as a panelist and presenter on the future of AI in healthcare.